| Code | 1077E | ||||||||||
| MA number | 44/0158/22-S | ||||||||||
| Product Form: | cps mol 4x1x30 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | medac Gesellschaft für klinische Spezialpräparate m.b.H., Germany | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PVC/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 17.06.2022 |
| Validity: | 17.06.2027 |
| SPC: |
SPC_Vinorelbine medac 30 mg mäkké kapsuly_05.2024.pdf
|
| PIL: |
PIL_Vinorelbine medac 30 mg mäkké kapsuly_05.2024.pdf
|
| Safety feature | Yes |
| Data update: | 15.05.2024 |
